Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) needs to be stratified for its heterogeneity. Oncogenic driver alterations such as EGFR mutation, ALK translocation, ROS1 translocation, and BRAF mutation predict response to treatment for LUAD. Since oncogenic driver alterations may modulate immune response in tumor micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian-Zhao, Gong, Chen, Xie, Zheng-Fu, Zhao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876383/
https://www.ncbi.nlm.nih.gov/pubmed/33585210
http://dx.doi.org/10.3389/fonc.2020.593022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876383/
https://www.ncbi.nlm.nih.gov/pubmed/33585210
http://dx.doi.org/10.3389/fonc.2020.593022

Ejemplares similares